Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guidelines
Dr. Sam S. Chang presented “Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer:...
Read More
International Prostate Cancer Update 2017
Update on Radiopharmaceuticals: Choosing a Companion Drug to Radium-223
Dr. Daniel P. Petrylak presented “Update on Radiopharmaceuticals: Choosing a Companion Drug...
Read More
Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs, etc.
Dr. Daniel P. Petrylak presented “Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs,...
Read More
Targeting AR in Castration-Resistant Prostate Cancer
Dr. Raoul S. Concepcion presented “Targeting AR in Castration-Resistant Prostate...
Read More
Neuroendocrine Prostate Cancer (NEPC)
Dr. Jehonathan Pinthus presented “Neuroendocrine Prostate Cancer (NEPC)” at the 27th...
Read More
New Concepts in Androgen Deprivation Therapy
Dr. Thomas E. Keane presented “New Concepts in Androgen Deprivation Therapy” at the...
Read More
Point-Counterpoint: Early Chemotherapy is Better
Dr. Daniel P. Petrylak and Dr. Michael S. Cookson presented “Point-Counterpoint: Early...
Read More
S.A.2M.2 : The Best “Natural” and Researched Heart Healthy Pills for Patients Concerned About Prostate Cancer
Dr. Mark A. Moyad presented “S.A.2M.2: The Best ‘Natural’ and Heart Healthy...
Read More
The Benefits and Challenges (Present and Future) for the Urologist Treating mCRPC
Dr. Lawrence I. Karsh presented “The Benefits and Challenges (Present and Future) for the...
Read More
Advanced Disease: A Real Need for Understanding and Shared Care
Dr. Daniel P. Petrylak presented “Advanced Disease: A Real Need for Understanding and Shared...
Read More
An Update of the European/Swedish Screening Trial
Professor Per-Anders Abrahamsson, MD, PhD presented “An Update of the European/Swedish...
Read More
Non-genomic Biomarkers for Early Diagnosis and Prognosis Prevention of Prostate Cancer
Dr. Alan W. Partin presented “Non-genomic Biomarkers for Early Diagnosis and Prognosis...
Read More